To date Spain is a country, where the health system succeeded to organize one of the most successful models transplantologic service.
A pharmaceutical firm based in Hyogo is set to submit an application for government approval of cultured cells (stem cells) as medicine, the first firm in Japan to do so. This medical treatment is aimed at bone marrow transplant patients, to help reduce the side effects of the procedure.
A new stem cell treatment may help heart attack patients do something once thought medically impossible — regenerate dead heart muscle.
For nearly three decades, the umbilical cord blood is increasingly used in clinical practice as a source of hematopoietic stem cells, alternative to bone marrow of an adult body.